Window dressing or financial needs?
21/12/20 -"Bayer placed ~75% of its 72.9 million Elanco shares with institutional investors for USD30.25 per share, which is below the USD31.55 per share Bayer accepted as acquisition currency. However, Bayer ..."
Pages
66
Language
English
Published on
21/12/20
You may also be interested by these reports :
27/01/21
We had expected Lonza’s FY 2020 release would be difficult to read, but the presentation of the figures with no helpful tables requires patience to ...
27/01/21
Novartis ended 2020 on a decent note, thanks to a sustained sales recovery momentum and impressive margin progression. While 2021 sales momentum is ...
26/01/21
Since our last Teaser in November 2019, it has been a roller-coaster ride for Sanofi (Buy, France). While an impressive mid-term growth strategy ...
30/12/20
With UK’s emergency use approval for Astra-Oxford’s COVID-19 vaccine candidate, the sentiment around Astra’s share price should improve finally. ...